ID

12148

Descripción

An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL).

Palabras clave

Versiones (3)
  1. 30/9/15 30/9/15 -
  2. 28/10/15 28/10/15 -
  3. 27/9/21 27/9/21 -
Subido en

30 de septiembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

CLL Completion NCT00090051 BO17072

Inglés

Treatment phase completion Chronic Lymphocytic Leukemia NCT00090051 BO17072

1 formularios  
In the case of patient’s death
Descripción

In the case of patient’s death

Alias
UMLS CUI-1
C0011065
Date of Death
Descripción

Date of Death

Tipo de datos

date

Unidades de medida
  • dd/mm/yy
Alias
UMLS CUI [1]
C1148348
dd/mm/yy
Cause of Death
Descripción

Primary Cause of Death

Tipo de datos

text

Alias
UMLS CUI [1]
C0007465
Cause of death
Descripción

Underlying cause of death (if applicable)

Tipo de datos

text

Alias
UMLS CUI [1]
C0007465
Death related to test drugs
Descripción

Relationship of death to test drugs

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0439849
UMLS CUI [1,2]
C0007465
Was autopsy performed?
Descripción

Autopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004398
Autopsy findings
Descripción

Autopsy findings

Tipo de datos

text

Alias
UMLS CUI [1]
C0004398
Comments
Descripción

General comments on patient's death

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C1306577
Treatment phase completion
Descripción

Treatment phase completion

Date of last dosing
Descripción

Date of last dosing

Tipo de datos

date

Unidades de medida
  • dd/mm/yy
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1762893
dd/mm/yy
Did the patient complete the study up to the end of the treatment phase?
Descripción

Study completion

Tipo de datos

boolean

Reason for no completion
Descripción

Reason for no completion

Tipo de datos

integer

Specify violation of selection criteria
Descripción

Specify violation of selection criteria

Tipo de datos

text

Specify other protocol violation
Descripción

Specify other protocol violation

Tipo de datos

text

Specify other reason
Descripción

Specify other reason

Tipo de datos

text

Additional observations
Descripción

Additional observations

Alias
UMLS CUI-1
C1524062
Additional observations
Descripción

Please record any significant clinical observations related to the trial drug, not reported in other parts of the CRF, including observations toward a possible therapeutic activity outside the studied indication and potential drug interactions.

Tipo de datos

text

Volver a la parte superior de la página

Similar models

Treatment phase completion Chronic Lymphocytic Leukemia NCT00090051 BO17072

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
In the case of patient’s death
C0011065 (UMLS CUI-1)
Date of Death
Item
date
C1148348 (UMLS CUI [1])
Cause of Death
Item
text
C0007465 (UMLS CUI [1])
Cause of death
Item
text
C0007465 (UMLS CUI [1])
Item
Death related to test drugs
integer
C0439849 (UMLS CUI [1,1])
C0007465 (UMLS CUI [1,2])
Death related to test drugs
Code List
Death related to test drugs
CL Item
unrelated (1)
C0445356 (UMLS CUI-1)
CL Item
remote (2)
C0205157 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
probable (4)
C1709683 (UMLS CUI-1)
Autopsy
Item
Was autopsy performed?
boolean
C0004398 (UMLS CUI [1])
Autopsy findings
Item
Autopsy findings
text
C0004398 (UMLS CUI [1])
Comments
Item
text
C0947611 (UMLS CUI [1,1])
C1306577 (UMLS CUI [1,2])
Item Group
Treatment phase completion
Date of last dosing
Item
date
C0011008 (UMLS CUI [1,1])
C1762893 (UMLS CUI [1,2])
Study completion
Item
Did the patient complete the study up to the end of the treatment phase?
boolean
Reason for no completion
Code List
Reason for no completion
CL Item
adverse event/intercurrent illness (1)
CL Item
death (complete death page) (2)
CL Item
insufficient therapeutic response (3)
CL Item
failure to return (4)
CL Item
violation of selection criteria at entry (5)
CL Item
other protocol violation (6)
CL Item
refused treatment/did not cooperate/withdrew consent (7)
CL Item
early improvement (8)
CL Item
administrative/other (9)
Specify violation of selection criteria
Item
text
Specify other protocol violation
Item
text
Specify other reason
Item
text
Item Group
Additional observations
C1524062 (UMLS CUI-1)
Additional observations
Item
text
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial